Subcutaneous recombinant factor IX administration produces therapeutic levels of F.IX activity in hemophilia B dogs - Brinkhous, K M; Sigman, J L; Read, M S; Stewart, P F; Bush, L; Bartlett, E; Rup, B; Keith, J C; Garzone, P; McCarthy, K; Schaub, R G (Blood, 1996)